Variant report
Variant | esv3339720 |
---|---|
Chromosome Location | chr6:160720198-160720551 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7747292 | chr6:160720209-160720210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs367967487 | chr6:160720211-160720212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs678413 | chr6:160720212-160720213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371342073 | chr6:160720216-160720217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372015533 | chr6:160720228-160720229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149882974 | chr6:160720229-160720230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148205130 | chr6:160720230-160720231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114785002 | chr6:160720231-160720232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116890233 | chr6:160720232-160720233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373740767 | chr6:160720235-160720236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139752981 | chr6:160720236-160720237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372130202 | chr6:160720238-160720239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144672995 | chr6:160720239-160720240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57016469 | chr6:160720240-160720241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs57456944 | chr6:160720241-160720242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376973690 | chr6:160720242-160720243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113760830 | chr6:160720244-160720245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367544909 | chr6:160720246-160720247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142807414 | chr6:160720247-160720248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369615999 | chr6:160720260-160720261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs386707802 | chr6:160720261-160720262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372435369 | chr6:160720264-160720265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377221364 | chr6:160720265-160720266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369689838 | chr6:160720267-160720268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114761858 | chr6:160720268-160720269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377100091 | chr6:160720279-160720280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372312110 | chr6:160720283-160720284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs66629748 | chr6:160720288-160720289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377012758 | chr6:160720291-160720292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368185446 | chr6:160720326-160720327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201196695 | chr6:160720342-160720343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184218622 | chr6:160720345-160720346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368154884 | chr6:160720349-160720350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7768243 | chr6:160720352-160720353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199678548 | chr6:160720360-160720361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369339049 | chr6:160720368-160720369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376584627 | chr6:160720394-160720395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111818415 | chr6:160720405-160720406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558028681 | chr6:160720410-160720411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537789227 | chr6:160720425-160720426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11452007 | chr6:160720426-160720427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112247285 | chr6:160720429-160720430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113074333 | chr6:160720431-160720432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559430931 | chr6:160720433-160720434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370171132 | chr6:160720434-160720435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373241630 | chr6:160720442-160720443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528604504 | chr6:160720466-160720467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139118949 | chr6:160720505-160720506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547187913 | chr6:160720512-160720513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560535 | chr6:160720531-160720532 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160710400-160721200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:160715200-160720600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr6:160715400-160720600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr6:160715400-160720600 | Weak transcription | HMEC | breast |
5 | chr6:160715400-160720600 | Weak transcription | NHEK | skin |
6 | chr6:160715400-160721800 | Weak transcription | HSMMtube | muscle |
7 | chr6:160715600-160720400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:160718400-160723600 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr6:160718600-160720800 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr6:160719200-160721400 | Weak transcription | Aorta | Aorta |
11 | chr6:160719200-160721400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
12 | chr6:160719800-160722600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr6:160720000-160720200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr6:160720200-160720600 | Enhancers | Duodenum Mucosa | Duodenum |
15 | chr6:160720200-160721600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr6:160720400-160720600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr6:160720400-160720800 | Enhancers | Hela-S3 | cervix |
18 | chr6:160720400-160721000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr6:160720400-160721800 | Enhancers | HUES48 Cell Line | embryonic stem cell |